Prostate Carcinoma Pc3 Cells
Prostate Carcinoma Pc3 Cells - Related Videos
05:07
Intra-prostatic Injection of Cancer Cells: A Technique to Deliver Cancer Cells for Establishing Orthotopic Prostate Cancer Mouse Model
0 Views •
2023
In this video, we demonstrate the procedure for administering intra-prostatic injection of prostate cancer cells into a mouse model. Orthotopic murine models can be used to study the disease origin and response to treatment therapies in a non-invasive and clinically relevant environment.
08:38
Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
0 Views •
Cited by 13 •
2013
We describe the manufacture of compressed hormone pellets, as well as subcutaneous surgical implantation into mice. This strategy can be combined with the growth of cell and tissue xenografts under the renal capsule of athymic nude mice to evaluate hormonal carcinogenesis and regulation of benign prostate growth.
02:34
Individual Lobe Extraction from Prostate: A Technique to Harvest Individual Prostate Lobes from Mouse Prostate
0 Views •
2023
This video describes a technique to harvest individual lobes from the prostate gland of a mouse model. Individual lobes can then be used for histological analysis and cancer research.
07:16
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
0 Views •
Cited by 6 •
2014
The isolation of cancer stem cells (CSCs) directly from human tissues is requisite for their biological characterization. This manuscript describes a methodology for the isolation of prostate CSCs from human tissues, while also providing tips on troubleshooting difficult steps.
04:16
Prostate Organoid Assay: A Matrix Gel Ring-based Ex Vivo Culture Technique to Study the Differentiation Capacity of Prostate Epithelial Cells
0 Views •
2023
In this video, we demonstrate the culturing of isolated mouse prostate epithelial cells using a matrix gel-ring based culture technique. This approach can provide complementary information about the differentiation capacity of prostate epithelial cells to form 3D glandular structures in response to genetic or pharmacological manipulation.
FAQs
PC3 cells allow investigators to examine cancer behavior without relying on functional androgen receptor signaling. This makes them useful for studying growth, survival, and treatment responses that persist when hormone-directed control is ineffective. In cancer research, experiments with this model can therefore focus on disease processes associated with advanced, androgen-independent prostate cancer rather than androgen-dependent regulation.
The cells were derived from a prostate cancer bone metastasis, giving them direct relevance to research on metastatic disease. Their use supports investigations into behaviors associated with advanced cancer, including migration, invasion, and survival. This origin does not make the line a complete model of metastasis, but it provides a specific context for studying prostate cancer progression.
PC3 cells support studies of several cancer-related behaviors, including proliferation, survival, migration, and invasion. Researchers can also examine tumor-associated signaling and responses to anticancer compounds. Considering these outcomes together helps distinguish effects on cell growth from effects on movement, invasive behavior, or signaling, producing a broader view of cancer-cell biology.
A single cell line cannot represent the biological diversity of prostate cancer. PC3-based results should therefore be interpreted alongside findings from other prostate cancer models, especially when conclusions concern disease behavior or therapeutic response. This comparison helps researchers determine whether an observed effect reflects a broader cancer property or a feature specific to this experimental line.
In culture, investigators can use PC3 cells in assays that measure proliferation, survival, migration, invasion, tumor signaling, and responses to anticancer compounds. The appropriate assay depends on the biological question, such as whether a treatment changes cell abundance, persistence, movement, invasive behavior, or signaling. These experiments provide distinct readouts rather than one universal measure of cancer activity.
Researchers can expose cultured PC3 cells to anticancer compounds and assess resulting changes in proliferation or survival. Additional measurements may examine migration, invasion, or tumor signaling when the research question extends beyond cell growth. Because these cells model androgen-independent disease, compound responses can be especially relevant to treatments aimed at cancer behavior that persists despite hormone-directed treatment.
PC3-cell experiments provide a model for examining cancer behaviors and treatment responses associated with advanced, androgen-independent disease. Researchers can investigate how compounds affect survival, proliferation, signaling, migration, or invasion under this disease context. The resulting evidence can inform studies of therapeutic resistance, but conclusions require comparison with other models to account for prostate cancer diversity.